Pingping Mao

972 total citations
16 papers, 241 citations indexed

About

Pingping Mao is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Pingping Mao has authored 16 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Pingping Mao's work include Advanced Breast Cancer Therapies (7 papers), Fibroblast Growth Factor Research (4 papers) and Cancer-related Molecular Pathways (4 papers). Pingping Mao is often cited by papers focused on Advanced Breast Cancer Therapies (7 papers), Fibroblast Growth Factor Research (4 papers) and Cancer-related Molecular Pathways (4 papers). Pingping Mao collaborates with scholars based in United States, China and Spain. Pingping Mao's co-authors include Nikhil Wagle, Ofir Cohen, Michael J. Spinella, Seth A. Wander, Eric P. Winer, Kailey J. Kowalski, Nancy U. Lin, David E. Root, Vincent A. Miller and Jon Chung and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Pingping Mao

15 papers receiving 238 citations

Peers

Countries citing papers authored by Pingping Mao

Since Specialization

Citations

This map shows the geographic impact of Pingping Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingping Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingping Mao more than expected).

Fields of papers citing papers by Pingping Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingping Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingping Mao. The network helps show where Pingping Mao may publish in the future.

Co-authorship network of co-authors of Pingping Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Pingping Mao. A scholar is included among the top collaborators of Pingping Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingping Mao. Pingping Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	OAB-007: Updated clinical and correlative results from the Phase I CRB-402 study of the BCMA-targeted CAR T cell therapy bb21217 in patients with relapsed and/or refractory multiple myeloma 2022 ·Clinical Lymphoma Myeloma & Leukemia ·Noopur Raje, Melissa Alsina, Nina Shah, Sundar Jagannath, Jonathan L. Kaufman, David S. Siegel, Nikhil C. Munshi, Jacalyn Rosenblatt, Yi Lin, Andrzej Jakubowiak, (unknown), Pingping Mao, (unknown), Ashish Yeri, Nathan Martin, (unknown), Fabio Petrocca, Olivia Finney, Anna Truppel-Hartmann, Jesús G. Berdeja	1
2	Cell Line–Specific Network Models of ER+ Breast Cancer Identify Potential PI3Kα Inhibitor Resistance Mechanisms and Drug Combinations 2021 ·Cancer Research ·Jorge Gómez Tejeda Zañudo, Pingping Mao, (unknown), Kailey J. Kowalski, Gabriela N. Johnson, Guotai Xu, José Baselga, Maurizio Scaltriti, Anthony Letai, Joan Montero, Réka Albert, Nikhil Wagle	18
3	Spatial and temporal variations in fractional vegetation cover and its driving factors in the Hulun Lake region 2021 ·Ecological Indicators ·Pingping Mao, Jing Zhang, Ming Li, Yiliang Liu, Xu Wang, (unknown), Beibei Shen, Xiang Zhang, Jie Shen, Xiaoyu Zhu, Dawei Xu, Xiaoping Xin	38
4	Abstract PD7-08: Igf1r mediates cdk4/6 inhibitor (cdk4/6i) resistance in tumor samples and in cellular models 2021 ·Cancer Research ·Seth A. Wander, Pingping Mao, Maxwell R. Lloyd, Gabriela N. Johnson, Kailey J. Kowalski, Utthara Nayar, Lillian M. Guenther, Kimberly Stegmaier, Eric P. Winer, Nancy U. Lin, Nikhil Wagle	2
5	Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer 2020 ·Clinical Cancer Research ·Pingping Mao, Ofir Cohen, Kailey J. Kowalski, (unknown), Jorge E. Buendia-Buendia, Michael S. Cuoco, Pedro Exman, Seth A. Wander, Adrienne G. Waks, Utthara Nayar, Jon Chung, Samuel S. Freeman, Orit Rozenblatt–Rosen, Vincent A. Miller, Federica Piccioni, David E. Root, Aviv Regev, Eric P. Winer, Nancy U. Lin, Nikhil Wagle	90
6	Abstract GS2-02: Acquired activating mutations in RTKs confer endocrine resistance in ER+ metastatic breast cancer through ER-reprogramming, MAPK signaling, and an induced stem-like cell state 2020 ·Cancer Research ·Ofir Cohen, Pingping Mao, Utthara Nayar, (unknown), Dewey Kim, Esha Jain, Karla Helvie, Daniel L. Abravanel, Kailey J. Kowalski, (unknown), Samuel S. Freeman, (unknown), Seth A. Wander, Adrienne G. Waks, Gad Getz, Aviv Regev, (unknown), Nancy U. Lin, Nikhil Wagle	1
7	Abstract 314: Acquired FGF and FGFR alterations confer resistance to estrogen receptor (ER) targeted therapy in metastatic ER+ breast cancer 2019 ·Cancer Research ·Pingping Mao, Ofir Cohen, Kailey J. Kowalski, (unknown), (unknown), Pedro Exman, Seth A. Wander, Adrienne G. Waks, Eric P. Winer, Nancy U. Lin, Nikhil Wagle	1
8	Abstract 314: Acquired FGF and FGFR alterations confer resistance to estrogen receptor (ER) targeted therapy in metastatic ER+ breast cancer 2019 ·Pingping Mao, Ofir Cohen, Kailey J. Kowalski, (unknown), (unknown), Pedro Exman, Seth A. Wander, Adrienne G. Waks, Eric P. Winer, Nancy U. Lin, Nikhil Wagle	0
9	Whole exome sequencing (WES) in hormone-receptor positive (HR+) metastatic breast cancer (MBC) to identify mediators of resistance to cyclin-dependent kinase 4/6 inhibitors (CDK4/6i). 2018 ·Journal of Clinical Oncology ·Seth A. Wander, Ofir Cohen, Gabriela N. Johnson, Dewey Kim, Flora Luo, Pingping Mao, Utthara Nayar, Karla Helvie, Lori Marini, Samuel S. Freeman, Gad Getz, Levi A. Garraway, Eric P. Winer, Nancy U. Lin, Nikhil Wagle	11
10	Abstract PD4-01: The role of FGF/FGFR axis in resistance to SERDs and CDK4/6 inhibitors in ER+ breast cancer 2018 ·Cancer Research ·Pingping Mao, (unknown), Ofir Cohen, Nikhil Wagle	14
11	Abstract P3-03-08: A large-scale functional screen to identify resistance mechanisms to selective estrogen receptor degraders fulvestrant and GDC-810 in ER+ breast cancer 2017 ·Cancer Research ·Pingping Mao, (unknown), Ofir Cohen, Federica Piccioni, Nikhil Wagle	1
12	Headway and Hurdles in the Clinical Development of Dietary Phytochemicals for Cancer Therapy and Prevention: Lessons Learned from Vitamin A Derivatives 2014 ·The AAPS Journal ·Christina Y. Yim, Pingping Mao, Michael J. Spinella	4
13	Abstract 4605: STK17A is a potential therapeutic target in glioblastoma 2014 ·Cancer Research ·Pingping Mao, (unknown), Gilbert J. Rahme, Eric C. Yang, Janice Tam, (unknown), Bijesh Kumar Biswal, Camilo E. Fadul, Arti Gaur, Mark A. Israel, Alexandre A. Pletnev, Michael J. Spinella	1
14	Serine/Threonine Kinase 17A Is a Novel Candidate for Therapeutic Targeting in Glioblastoma 2013 ·PLoS ONE ·Pingping Mao, (unknown), Gilbert J. Rahme, Eric C. Yang, Janice Tam, (unknown), Bijesh Kumar Biswal, Camilo E. Fadul, Arti Gaur, Mark A. Israel, Michael J. Spinella	26
15	Abstract 2958: The novel protein kinase STK17A is a direct p53 target gene that mediates response to genotoxic and nutritional stress in a cancer cell context-dependent manner 2012 ·Cancer Research ·Pingping Mao, (unknown), (unknown), (unknown), Eric Yang, (unknown), (unknown), (unknown), Joanna S. Kerley-Hamilton, Sarah J. Freemantle, Michael J. Spinella	1
16	Serine/Threonine Kinase 17A Is a Novel p53 Target Gene and Modulator of Cisplatin Toxicity and Reactive Oxygen Species in Testicular Cancer Cells 2011 ·Journal of Biological Chemistry ·Pingping Mao, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Joanna S. Kerley-Hamilton, Sarah J. Freemantle, Michael J. Spinella	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact